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Deubiquitinating enzymes (Dubs) function to remove
covalently attached ubiquitin from proteins, thereby
controlling substrate activity and/or abundance. For
most Dubs, their functions, targets, and regulation
are poorly understood. To systematically investigate
Dub function,we initiated a global proteomic analysis
of Dubs and their associated protein complexes. This
was accomplished through the development of a
software platform called CompPASS, which uses
unbiased metrics to assign confidence measure-
ments to interactions from parallel nonreciprocal
proteomic data sets. We identified 774 candidate
interacting proteins associated with 75 Dubs. Using
Gene Ontology, interactome topology classification,
subcellular localization, and functional studies, we
link Dubs to diverse processes, including protein turn-
over, transcription, RNA processing, DNA damage,
and endoplasmic reticulum-associated degradation.
This work provides the first glimpse into the Dub inter-
action landscape, places previously unstudied
Dubs within putative biological pathways, and iden-
tifies previously unknown interactions and protein
complexes involved in this increasingly important
arm of the ubiquitin-proteasome pathway.
INTRODUCTION
Reversible modification of target proteins with ubiquitin regu-
lates an assortment of signaling pathways either through protea-
somal degradation or by altering the activity and/or localization
of constituent proteins. Ubiquitin conjugation is mediated via
an E1-E2-E3 cascade, whereas ubiquitin removal is catalyzed
by deubiquitinating enzymes (Dubs) (Ventii and Wilkinson,
2008). The human genome encodes 95 Dubs in five major
classes (Nijman et al., 2005b). Four of these classes use an
active site cysteine as a nucleophile to attack lysine-glycine
isopeptide bonds within ubiquitinated proteins: ubiquitin-
specific proteases (USPs), otubain domain-containing proteins(OTUs), Machado-Joseph domain (Josephin domain)-containing
proteins (MJD), and ubiquitin C-terminal hydrolases (UCHs) (Nij-
man et al., 2005b). In contrast, the fifth class of Dubs contains
a JAMM zinc metalloproteinase domain (Cope and Deshaies,
2003). Several proteins with USP or JAMM domains lack critical
active site residues and may be catalytically inactive (Nijman
et al., 2005b); however, for simplicity we will refer to all proteins
that contain one of these five classes of domains (both active and
inactive) as Dubs.
While progress in understanding Dub function has lagged
behind that of the conjugation machinery, a number of recent
studies have revealed central roles for Dubs in controlling cell
signaling events. CYLD and TNFAIP3/A20 negatively regulate
the NFkB pathway by removing ubiquitin chains from multiple
signalingmolecules, including TRAFs andRIP (Sun, 2008).Muta-
tions in CYLD are found in familial cylindromatosis (Sun, 2008),
and CYLD has also been independently implicated in the G2/M
transition (Stegmeier et al., 2007b). Several Dubs, including
MYSM1, USP16, USP3, and USP22, have been implicated in
the deubiquitination of histones (Pijnappel and Timmers, 2008;
Zhang, 2003), while USP1, USP7, USP28, USP3, and BRCC36
have been implicated in the DNA damage response (Nijman
et al., 2005a; Sobhian et al., 2007; Zhang et al., 2006; Nicassio
et al., 2007). We have previously shown that USP44 deubiquiti-
nates CDC20 to negatively regulate the anaphase-promoting
complex during the spindle checkpoint (Stegmeier et al.,
2007a). Although it is becoming increasingly apparent that
Dubs regulate various cellular processes, the targets and func-
tions of Dubs are poorly understood (Ventii andWilkinson, 2008).
The limited understanding of the biological context in which
Dubs act led us to initiate a global proteomic analysis of the
Dub protein family in order to identify stably associated interact-
ing proteins, thereby aiding in the elucidation of the biological
functions of this important class of enzymes. In principle, the
identity of associated proteins can be used to gain insight into
the possible biological functions and regulatory mechanisms
of Dubs. For example, four Dubs (USP14, UCHL5/Uch37,
PSMD14/RPN11, and PSMD7/RPN8) are known to associate
with the proteasome, and subsequently three have been shown
to function in chain removal or editing of ubiquitinated protea-
some substrates (Cope and Deshaies, 2003; Ventii and Wilkin-
son, 2008). To expedite the elucidation of the Dub interactome,
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Software Suite (CompPASS), described herein, which employs
an unbiased methodology for the identification of high-confi-
dence candidate interacting proteins (HCIPs) from parallel
nonreciprocal proteomic data and facilitates functional dissec-
tion of interaction networks. We analyzed 75 of the 95 Dubs
encoded by the human genome, leading to the identification of
774 unique HCIPs and an overall experimental validation rate
of 68%. This represents a greater than 7-fold increase in the
number of high-confidence Dub interacting proteins previously
reported in the literature, and includes interactions for many
Dubs for which no information was previously available.
Utilizing GeneOntology (GO), interactome topology classifica-
tions, and subcellular localization studies, we link Dubs and their
interacting partners with diverse biological processes. One-third
of the Dubs analyzed are associated with established protein
complexes involved with protein turnover, transcription, RNA
processing, or DNA damage response. Other Dubs were found
to interact with a diverse collection of seemingly unrelated
proteins or, alternatively, had very few interaction partners. In
keeping with their role in ubiquitin biology, 26 Dubs were found
to associate with one or more proteins that contain domains
linked to ubiquitin conjugation, including HECT and Cullin-based
E3 ubiquitin ligases, suggesting cross-regulation within the ubiq-
uitin system. We identified six Dubs as likely interactors of VCP/
p97, a AAA ATPase known to play roles in ubiquitin binding and
delivery to the proteasome, particularly in the context of the
endoplasmic reticulum (ER)-associated degradation (ERAD)
pathway (Vembar and Brodsky, 2008). Two of these Dubs,
VCPIP1 and USP13, associate with multiple known VCP inter-
acting proteins, suggesting that they engage a functional VCP
complex. We found that depletion of USP13 by RNA interference
(RNAi) resulted in the accumulation of a model ERAD substrate,
TCRaGFP (DeLaBarre et al., 2006), and an increase in the sensi-
tivity of cells to tunicamycin, a drug known to stimulate cell
death via the unfolded protein response (Malhotra and Kaufman,
2007). This suggests that USP13 plays a role in the ERAD
pathway, as would be predicted on the basis of our Dub interac-
tion landscape. The proteomic and informatics platform we have
developed has allowed us to begin to define the Dub interaction
landscape and to assign putative biological functions for previ-
ously unstudied Dubs.
RESULTS AND DISCUSSION
Systematic Proteomics of Deubiquitinating Enzymes
Interaction proteomics provides the most direct approach avail-
able for identifying physiologically relevant protein complexes
and networks but is often difficult to apply to large collections
of proteins due to the experimental resources required and the
large number of nonspecific interacting proteins that typically
dominate the mass spectral analysis of immune complexes (Ew-
ing et al., 2007). In order to address these issues and begin to
define the landscape of the Dub interactome, we have estab-
lished a facile platform for interaction proteomics that includes
a readily scalable expression and purification strategy using a
retroviral mediated expression library of 75 Flag-HA tagged
Dubs (Table S2 available online) in combination with new meth-
odology for defining HCIPs from parallel LC-MS/MS data sets390 Cell 138, 389–403, July 24, 2009 ª2009 Elsevier Inc.(Figure 1A and the Supplemental Experimental Procedures).
Sixty-nine of the 75 Dubs analyzed in this study are endoge-
nously expressed in human embryonic kidney (HEK) 293 cells
(Figure S1), indicating that this is a suitable system in which to
systematically identify proteins associated with Dubs. Each
Dub was purified with anti-HA antibody-coupled resin, and tryp-
sinized complexes were subjected directly to LC-MS/MS in
duplicate (Supplemental Experimental Procedures) to create
a database of Dub-associated proteins. Flag-HA-Dub expres-
sion varied over a wide range, yet no correlation was observed
between Dub protein levels and their number of HCIPs deter-
mined as described below (a correlation would be expected if
overexpression consistently led to increases in nonphysiological
interactions) (Figures 1B and 1C). This also demonstrates that we
were able to identify HCIPs over a wide range of Dub expression
levels.
The identification of bona fide interactions remains an
outstanding problem for proteomic analysis of immune
complexes and, toward this end, multiple methods have been
developed (Collins et al., 2007; Ewing et al., 2007; Gavin et al.,
2002; Krogan et al., 2006; Sardiu et al., 2008). Although these
methods have been successfully applied to specific data, certain
limitations exist, especially with regards to nonreciprocal data
sets such as observed with our Dub data set (see the Supple-
mental Results). As an alternative to these approaches, we
have developed an unbiased comparative approach to identify
HCIPs in parallel proteomic data sets using a software platform
called CompPASS. CompPASS performs better on nonrecip-
rocal data sets than existing methods, does not rely on a training
set of ‘‘gold standard’’ or previously reported interactions, and
does not require the expense associated with the use of stable
isotopic labeling with amino acids in culture (SILAC) for back-
ground protein identification (for a comparison of CompPASS
and other methods, see the Supplemental Results, Figures S4
and S5, and Table S1).
CompPASS: A Software Platform for Comparative
Proteomic Analysis
CompPASS is composed of an automated MS/MS data-pro-
cessing component, a protein function/annotation component,
and an interaction network analysis component, which, together,
form an integrated platform for analyzing parallel proteomic data
(Figures 1D, 1E, and S2 and the Supplemental Experimental
Procedures). The centerpiece of CompPASS is the data-pro-
cessing component, which employs an unbiased comparative
methodology to assign scores to proteins identified within
parallel proteomic data sets.
Our approach employs two scoringmetrics that are calculated
on the basis of a ‘‘stats table,’’ where the columns are individual
IP-MS/MS experiments, the rows are bait-associated proteins,
and each element is populated with the total spectral counts
(TSCs; used to approximate protein abundance; Liu et al.
[2004]) for each identified protein from each IP-MS/MS experi-
ment (Figure 1E). The first metric is the conventional Z score
(Figure 1E, Equations 1 and 2), which is most useful when
analyzing proteins that are present in multiple immune
complexes but are found at much higher levels in a subset of
these. A drawback of the Z score is that it equally weights unique
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Figure 1. CompPASS: A Platform for Semi-High Throughput Proteomic Analysis of Protein Complexes and Its Application to Dubs
(A) Schematic illustration of the major steps in our parallel proteomics platform (see the Supplemental Experimental Procedures).
(B) The total spectral counts for each bait protein (blue bars) is shown together with the corresponding number of HCIPs for the corresponding Dub (red bars)
(DN scoreR1).
(C) Distribution of bait abundance across 75 Dubs analyzed.
(D) Schematic representation of CompPASS showing components for storage, organization, and analysis of data from parallel proteomic data sets (top), linked
with networking and functional analysis tools for identification of protein complexes and biological functions (bottom) (see the Supplemental Experimental Proce-
dures).
(E) Automated processing andmetrics determination within the computational component ofCompPASS. The Z score is calculated with Equations 1 and 2, while
the DR score is calculated as described in Equation 3, where k is the total number of IP-MS/MS runs in the stats table. Determination of the DT score is depicted in
the graph displaying the distribution of DR scores from simulated data (see the Supplemental Experimental Procedures). The normalizedD score (DN) is calculated
with Equation 4.Cell 138, 389–403, July 24, 2009 ª2009 Elsevier Inc. 391
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Figure 2. D and Z Scores as Metrics for Identification of High-Confidence Candidate Interacting Proteins from Parallel Proteomic Data
(A and B) Plot of the DN score versus Z score for proteins identified in the COPS6 IP-MS/MS data set (multicolored dots) overlaid with the Z and DN scores for the
EGFP data set (green dots) (A). Silver stained gel of the COPS6 immune complex is shown on the left. HCIPs cluster in the upper-right quadrant (gray box). Colors
of individual proteins correspond to signalosome proteins and components of Cullin-based E3s identified as COPS6 HCIPs (B) with known associated proteins
marked with an asterisk.
(C–E) Percent overlap of interacting proteins compared between four USP11 IP-MS/MS data sets (blue bars) and all biological replicates across four Dubs (red
bars) or the merged USP11 analyses and EGFP (green bars) and all biological replicates (orange bars) for HCIPs (DN > 1) (left) or the totality of interacting proteins392 Cell 138, 389–403, July 24, 2009 ª2009 Elsevier Inc.
interactors regardless of their TSC. To address this issue, we
have devised a newmetric, whichwe term theD score (Figure 1E,
Equation 3). The D score incorporates the uniqueness, the abun-
dance of the interactor (TSC), and the reproducibility of the inter-
action to assign a score to each protein within each IP (the same
protein in two different IPs may have distinct D scores since its
TSC and reproducibility could differ). In this way, the highest
scores are given to proteins in each IP that are found rarely,
found in duplicate runs, and have high TSCs—all characteristics
of proteins that would be considered candidate interactors. A
global D score threshold (DT) is determined and all raw D scores
(DR) are normalized to this value, producing DN scores
(Figure 1E, Equation 4, and Figure S3; Supplemental Experi-
mental Procedures). Interactors in each IP with a DN score R1
are consideredHCIPswhile thosewith DN score <1 are less likely
to be bona fide interactors (examination of Z scores in this case
can facilitate the identification of candidate interactors). All data
reported here were calculated from a stats table populated with
data derived from 76 immune complexes (75 Dubs and EGFP as
a control), analyzed in duplicate (Table S3).
Application of CompPASS to Macromolecular
and Distributive Complexes
The ability of Z andDN scores to identify HCIPswithin the context
of a macromolecular complex is exemplified by analysis of
proteins associated with COPS5 andCOPS6, active and inactive
JAMM motif components of the COP9/signalosome complex,
respectively (Cope and Deshaies, 2003). When ranked by DN
score, the nine known subunits of the signalosome (COPS1–6,
COPS7A and COPS7B, and COPS8) are found within the top
20 (of 284) COPS6-associated proteins, with six of the top ten
proteins being core signalosome components (Figures 2A and
2B). The best understood role of the signalosome is to remove
the ubiquitin-like protein Nedd8 from the Cullin family of E3 ubiq-
uitin ligases, an event catalyzed by the COPS5 subunit (Cope
and Deshaies, 2003), and accordingly, 42 of the top 50 DN
score-ranked non-core signalosome proteins identified in asso-
ciation with COPS6 include Cullins, Nedd8, and Cullin-based
substrate adaptors (including F Box and BTB proteins not previ-
ously known to bind CUL1 or CUL3; Figures 2D and 2H). The
Cullin adaptors captured here may represent either the most
abundant adaptors or those with the highest residence time on
the signalosome. While DN scores are useful in identifying HCIPs
from relatively unique interacting proteins, Z scores allow for the
identification of candidate interacting proteins that are found
frequently across multiple baits. For example, CUL3 is detected
in 32% of all Dub LC-MS/MS data sets as well as the EGFP
control data set, but its Z score (5.79) identifies CUL3 as a candi-
date interactor for COPS6 but not for EGFP (Figure 2B and Table
S3). Analysis of HCIPs for COPS5 revealed all but three of the
proteins found in the COPS6 analysis (Figure 2F), demonstratingthe usefulness of our platform in identifying constituents of multi-
protein complexes in a reciprocal manner.
We evaluated several other Dubs known to form multiprotein
complexes to assess the accuracy of our scoring criteria. While
this work was in process, USP22 was shown to associate with
several subunits of the SAGA transcriptional regulatory complex
(Zhang et al., 2008; Zhao et al., 2008). Of the 28 HCIPs from 384
total proteins identified in association with USP22, 14were either
known SAGA components, paralogs of known SAGA compo-
nents (ATXN7L2), or proteins that interact with SAGA compo-
nents in the yeast two-hybrid (Y2H) system (CCDC101 and
CNOT1) (Figure 2G). Further validating our approach, all 21
subunits of the 19S regulatory subcomplex of the proteasome
(Pickart and Cohen, 2004) were identified in HCIPs from
USP14, PSMD14, UCHL5, and PSMD7, with the exception of
the ADRM1 subunit, which was found in three of four protea-
some Dub complexes (Figure 2H, Table S3). With USP14, for
example, 23 of the top 25 (from 232) proteins ranked by DN score
were 19S or 20S subunits (Table S3). For a discussion of four
additional well-studied Dubs, see the Supplemental Results
and Figure S12.
To evaluate CompPASS for the identification of HCIPs within
the context of distributive complexes (i.e., baits with a variety of
interactors that tend not to interact with each other) we investi-
gated USP11 using four independent biological replicates and
three additional Dubs with biological replicates. On average,
complete data sets from biological replicates showed a 65%
overlapwith each other but only a 35%overlapwith EGFPcontrol
complexes (Figure 2C). Examination of HCIPs derived from the
USP11 and three additional Dub data sets revealed an 80%over-
lap among the biological replicates (Figure 2C), and more than
50% of HCIPs were found in at least three out of the four
USP11 biological replicates (Figures 2D and 2E). As expected,
proteins with higher TSCs were more reproducibly identified
(Figure 2D), but reproducibility itself does not accurately specify
a candidate interactor since the majority of proteins found in all
four USP11 replicates were deemed nonspecific by our metrics
(Figure 2E). Taken together, these results demonstrate that the
proteomic methodology used here, together with CompPASS,
allows us to filter out common false-positive interacting proteins
and identify a subset of associated proteins, HCIPs, that are
candidates for bona fide interacting proteins in both macromo-
lecular and distributive complexes. In practice, the combined
use of Z and DN scores provides the most effective approach
for identifying HCIPs (Figures 2A and S7).
An Overview of the Human Dub Interaction Landscape
Out of the 2458 uniquely identified proteins in our Dub data set,
774 were found to be HCIPs associated with 75 Dubs (Figures
3A and S8, and Table S3), with an overall validation rate of 68%
as described below. The diversity of interacting proteins among(right); error bars represent the SEM for HCIPs and background proteins amongst the four USP11 IP-MS data sets or triplicate IP-MS data sets for the other Dubs
(C). Breakdown of the fraction of interacting proteins found in increasing numbers of USP11 biological replicates for all identified proteins (blue bars) and HCIPs
(red bars) analyzed independently (D) or in combination (E) to display the percent of proteins in each category that were selected as HCIPs. The numbers above
the bars in (D) represent the average TSC for interactors within that category.
(F–H) Interaction networks for HCIPs found in COPS5 and COPS6 (F), USP22 (G), and Dubs associated with the proteasome regulatory particle (USP14, UCHL5,
PSMD14, and PSMD7) (H) were created with the networking tools in CompPASS. Maps were generated with Cytoscape with attribute files that reflect bait abun-
dance (size of bait [blue squares]), DN score (thickness of line), and Z score (color of line). PPI database interactions are shown as black dashed lines.Cell 138, 389–403, July 24, 2009 ª2009 Elsevier Inc. 393
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Figure 3. Interaction Landscape of 75 Human Dubs and Their Classification into Topological Categories
(A) Heat map generated from hierarchical clustering of the 774 HCIPs for 75 Dubs. The color of the interacting protein corresponds to its DN score.
(B) Interactions among HCIPs for each Dub were determined with CompPASS in conjunction with the STRING, BioGRID, and MINT PPI databases. The seven
topological groups based on the number of HCIPs and number of interactions among HCIPs are shown. Enlarged maps are provided in Figure S9.Dub complexes, as well as the specificity for individual Dubs, is
illustrated by hierarchical clustering of HCIPs and Dubs (Fig-
ure 3A). The vast majority of HCIPs are found only in complexes
with a single Dub, the exceptions being Dubs associated with
the signalosome, the EIF3 complex, and the proteasome. Addi-
tionally, two sets of Dubs were found to share a significant
number of HCIPs: USP12 and USP46 share five of their top-
ranked interacting proteins (WDR48, WDR20, DMWD, PHLPP,
andPHLPPL),whileUSP4,USP15, andUSP39share 14%of their
HCIPs, all of which are linked to mRNA processing (Figure 3A).
Analysis of HCIPs that cluster together for an individual Dub
can reveal proteins that participate in a complex, such as found394 Cell 138, 389–403, July 24, 2009 ª2009 Elsevier Inc.with USP22 (Figure 3A). Similarly, Dubs that associate with
multiple members of a protein family can also be identified,
such as USP49, which interacts with all three members of the
Centrin protein family and three members of the SAPS domain
family of phosphatase activators (Figure 3A).
Network Topology of the Dub Interaction Landscape
We next used protein-protein interaction (PPI) database tools
within CompPASS (Figure 1D) to organize Dubs into distinct
topological groups based on the number of HCIPs for each
Dub and the number of interactions among HCIPs (Figures 3B
and S9). Seven topological groups, each representing different
network profiles, were created and can provide insight into the
biological context in which member Dubs likely function. On
one extreme are Group 1 Dubs (28 members), which have no
more than six HCIPs, and no known interactions among HCIPs
(Figures 3B and S9D). Group 1 Dubs include USP28, which is
known to form a heterodimer with 53BP1 (Zhang et al., 2006).
On the other extreme are Group 2 and Group 3 Dubs, which
have over two dozen HCIPs with significant interconnectivity
among them (Figures 3B, S9E, and S9F). These include Dubs
that interact with the proteasome (USP14, UCHL5, PSMD7,
PSMD14), the EIF3 complex (EIF3S3, EIF3S5), and the SAGA
complex (USP22), and newly identified interactions between
Dubs and mRNA processing (USP4, USP15, USP39) and
transcriptional (JOSD3) and protein phosphatase scaffolding
(ZRANB1/TRABID) complexes (Figure 3B). Group 6 Dubs
contain at least nine HCIPs, with little known connectivity
(Figures 3B and S9I). However, we demonstrate below that
HCIPs for theGroup 6DubsUSP12 andUSP46 formmultiprotein
complexes, suggesting that the interconnectivity among HCIPs
for distributive Dubs may be underestimated.
Gene Ontology Analysis of the Dub Interaction
Landscape
In order to begin to place these 75 Dubs within a putative biolog-
ical context, we used tools within CompPASS to organize GO
process and component descriptions for each of the Dubs asso-
ciated HCIPs (Figures 4A–4C, the Supplemental Experimental
Procedures, and Table S8). GO process analysis linked Dubs
to a wide variety of functions, with 34% of Dubs containing at
least three HCIPs having GO terms associated with the ubiquitin
system (Figure 4C). Five hundred and fifty-two unique protein
interaction domains (Pfam) were identified among 774 HCIPs,
including some domain types (e.g., WD40) that were highly en-
riched among HCIPs (Figure S15). As described below, the
WD40 protein WDR48 has recently been demonstrated to func-
tion as an activator of several Dubs (Cohn et al., 2007, 2008).
Placement of Dubs within Biological and Cellular
Modules
Given the GO analysis discussed above and the extent of valida-
tion observed, we developed a cellular map of where and in what
processes Dubs are likely to function (Figure 4D). Functional
modules were ascribed on the basis of the presence of at least
three HCIPs in a particular GO category. However, given the
array of interacting proteins identified for certain Dubs (such as
Group 6 and 7 Dubs), many Dubs are likely to be involved with
multiple distinct pathways. Dubs with limited HCIPs or HCIPs
with disparate GO classifications were localized within the cell
by stable expression of GFP-Dub fusions in either HeLa or
293T cells (Figures 4D and S16). Interestingly, one-third of the
Dubs examined in this study can be placed within the nucleus
on the basis of either GFP localization or GO assignment (Figures
4A and 4D). Among these are six Dubs (USP11, USP22, USP7,
JOSD3, BRCC36, and BAP1) that can be placedwithin transcrip-
tional or DNA damage modules (Figures 4D and S12, and the
Supplemental Results). In addition, three Dubs (USP39, USP4,
and USP15) are implicated in mRNA processing by virtue of their
association with U5/U6-snRNP components. Other Dubs,including TNFAIP3/A20, USP21, USP46, USP12, ZRANB1, and
USP43, are linked with cytoplasmic phosphorylation-based
signaling systems (Figures 4D and S12, and the Supplemental
Results).
Dub Interactome Validation
Three independent approaches were used to validate our Dub
interaction data set. First, we stably expressed 25 Flag-HA-
tagged HCIPs found among 18 Dubs and performed IP-MS/
MS on purified complexes. Of the 40 binary interactions repre-
sented by this subset of HCIPs, 33 reciprocal interactions
(83%) were identified (Figure 5, Table S4). Second, a further
set of 20 Myc-tagged HCIPs (associated with five Dubs) or an
additional set of five Myc-tagged Dubs were expressed in either
293T cells stably expressing the appropriate HA-tagged Dub or
293T cells for detection of the endogenous HCIP. Immunoblot-
ting of anti-Myc immune complexes validated 14 of 29 expected
interactions (Figures 5 and S10). In all six cases tested, both
IP-MS/MS and IP-western methods gave identical results
(Figure 5). Third, we also validated three out of six binary interac-
tions using endogenous co-IP methods (Figures 5 and S10). In
total, 45 of 66 (68%) tested interactions were validated with at
least one independent method. Of note is the recent demonstra-
tion that other commonly used interaction mapping methods
such as Y2H are only able to detect 30% of known ‘‘gold-stan-
dard’’ binary interactions (Braun et al., 2009).
To determine what percentage of published Dub interacting
proteins we identify in our Dub interaction landscape, we em-
ployed the BioGRID PPI database (Stark et al., 2006) as well as
manual literature curation to identify reported interactions with
Dubs. In total, this identified 332 interactions associated with
51 Dubs (Table S7). Due to the inherent differences in the amount
of false-positive identifications among various interaction
mapping methodologies (Cusick et al., 2009), we categorized
these data by experimental system to separate interactions
determined by copurification and reconstitution methods from
those identified with Y2H. With the most stringent criteria
(endogenous co-IP or copurification), 71% of 91 interactions in
this category were found in our analysis, and >90% of these
had DN scores R1 (Figure S11, Table S7). When the less strin-
gent category of overexpression co-IP was examined, 36% of
previous interactions were found. In contrast, only 4.6% of inter-
actions that were previously observed only by Y2Hwere found in
our data set (Figure S11). This value is somewhat lower than the
overlap seen between independent large-scale Y2H screens
(11%–15%) (Futschik et al., 2007), as expected given that
many interactions are identified in only a single screen.
As a final test of the robustness and reproducibility of our
methodology, we performed IP-MS/MS experiments on 11
Dubs stably expressed in HCT116 cells. Fifty-four percent of
interactors that have DN scores R1 in our 293T data set are
also present when the same Dub was isolated from HCT116
cells (Figure S6). This is increased to 63% when considering
proteins with p < 0.01 (Figures S3 and S6, Table S5, and the
Supplemental Results). Closer examination of distributive Dub
complexes like USP11 and USP20 reveals that even interacting
proteins originally identified with less than ten TSCs are
identified when the same Dub was isolated from HCT116 cellsCell 138, 389–403, July 24, 2009 ª2009 Elsevier Inc. 395
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Figure 5. Experimental Validation of Selected Dub-HCIP Pairs
Selected Dub-HCIP pairs were validated with one of four methods. (1) In the reciprocal tagging MS approach, 293T cells with stable expression of a Flag-HA-
tagged HCIP (leftmost column in each set) were created, and subsequent LC-MS/MS analysis of HA-immune complexes was used to determine whether the
originally identified Dub (second column in each set) was present. A positive result indicates that indicated HCIP immune complex contained at least one peptide
from the Dub of interest. Numbers in parenthesis indicate the number of Dub TSCs within the HCIP immune complex and the corresponding DN score. (2) N-Myc-
tagged candidate interactors were transiently transfected into the corresponding Flag-HA-Dub stable cell line. Lysates were immunoprecipitated with anti-myc
resin and blotted for the Dub of interest with an HA antibody. (3) N-Myc-tagged Dubs were transfected into 293T cells. Lysates were immunoprecipitated
with anti-myc resin and blotted for the interactor of interest with antibodies that recognize the endogenous protein. (4) 293T lysates were immunoprecipitated
with antibodies against the endogenous Dub and immunoblotted with antibodies against the endogenous HCIP. See Figure S10 for primary western blot data.(Figures S6C and S6D). Taken together, these validation exper-
iments demonstrate the efficacy of our methodology and the
ability of our metrics in CompPASS to strongly enrich for bona
fide interacting proteins.TheDub InteractomeReveals NewRegulatory Networks
Linked with Core Cellular Functions
In order to explore the connectivity of interaction networks con-
taining both Dubs and their associated proteins, we performedFigure 4. Placement of Dubs within a Putative Biological Context
(A) Heat map of GO process (top) or component (bottom) terms (Table S8) associated with HCIPs for each Dub. The color of boxes corresponds to the number of
HCIPs from that Dub assigned to a GO-derived category, normalized across all Dubs.
(B and C) Distribution of 774 HCIPs into GO-derived categories (B) and percentages of Dubs (C) for each GO-derived category based on a minimum of either at
least two (blue bars) or at least three (red bars) HCIPs assigned to that category.
(D) Dubs with three or more HCIPs assigned to the same GO category were ascribed that cellular function (orange dots). A limited number of Dubs were localized
within the cell based the localization of GFP-Dub fusion proteins that were stably expressed in either HeLa or 293T cells (green dots) (Supplemental Experimental
Procedures). Dubs with both GFP localization data and GO assignments were placed accordingly (purple dots). Scale bars represent 10 mm.Cell 138, 389–403, July 24, 2009 ª2009 Elsevier Inc. 397
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Figure 6. Reciprocal Proteomic Analysis of HCIPs Identifies New Components of Core Cellular Functions
Cytoscape generated merged interaction maps of HCIPs found in at least two IP-MS/MS experiments among USP1, USP12, USP46, PHLPP, PHLLPL, WDR20,
WDR48, and DMWD (A), USP39, USP15, USP4, PRPF4, and SART3 (B), BRCC36, BRE, UIMC1, and HSPC142 (C), or USP10, G3BP1, and G3BP2 (D) immune
complexes. The color of the lines represents the identity of the bait involved in the association while black dashed lines are PPI database interactions.a reverse proteomic analysis of HCIPs found in several Dub
immune complexes. One such network, which we refer to as
the DPW (Dub, phosphatase, WD40) network, contains three
Dubs whose catalytic domains are most closely related to
each other in primary sequence (USP1, USP12, USP46),
WDR48, two related protein phosphatases (PHLPP, PHLPPL)
previously reported to dephosphorylate Akt (Mendoza and Ble-
nis, 2007), and two closely related but previously unstudied
WD40 proteins (WDR20 and DMWD) (Figure 6A, Table S4).
Both USP12 and USP46 were found to individually associate
with all three WD40 proteins and both phosphatases, while
USP1 associated with WDR48 and PHLPP but not WDR20,
DMWD, or PHLPPL. Reciprocal IP-MS/MS suggests the exis-
tence of multiple distinct Dub complexes in which USP12 (or
USP46) interacts with WDR48, WDR20 (or DMWD), and PHLPP
(or PHLPPL) (Figure 6A, Table S4). In contrast, USP1 forms
complexes with WDR48 and PHLPP with the exclusion of
WDR20 and DMWD. WDR48/UAF1 is an activator of USP1398 Cell 138, 389–403, July 24, 2009 ª2009 Elsevier Inc.(Cohn et al., 2007) andmore recently has been shown to activate
USP12 and USP46 (Cohn et al., 2008). The finding that 36% of
Dubs are associated with WD40 proteins (Figure S15) suggests
that this type of activating mechanism may be more prevalent
than currently appreciated. USP12 and USP46 are among
several Dubs categorized as being part of distributive networks
(Group 6, Figure 3B). Our analysis of these complexes reveals
that interconnectivity between proteins within distributive
complexes may be larger than currently appreciated, reflecting
the inadequacy of existing protein interaction data.
Previous studies have revealed the involvement of ubiquitin
conjugation and removal in the mRNA splicing pathway via the
U5/U6-snRNP complex in budding yeast (Bellare et al., 2008).
Consistent with these observations, we identified three Dubs
that associate with components of the U5/U6-snRNP as well
as other components involved in mRNA processing (Figure 6B,
Table S3). USP39 was previously shown to associate with
BCDIN3, a 7SK small nuclear RNA (snRNA) methylphosphate
capping enzyme that associates with U5/U6-snRNP (Jeronimo
et al., 2007). USP39 complexes contain 11 known subunits of
U5/U6-snRNP, suggesting a role for USP39 in mRNA splicing.
In contrast, USP4 and USP15 associated with five subunits of
the U5/U6-snRNP (PRPF31, PRPF3, BCDIN3, PRPF4, and
PPIH/cyclophilin H) as well as five and four subunits, respec-
tively, of the LSM mRNA binding complex (LSM2-8). Interest-
ingly, both USP4 and USP15 associated with Terminal Uridylyl
Transferase (TUT1), previously implicated in 30 uridylation of U6
snRNA (Trippe et al., 2006), but not known to associate with
the U5/U6-snRNP complex. In reciprocal LC-MS/MS experi-
ments, SART3 complexes contained the majority of U5/U6-
snRNP components as well as USP39 and USP4, and PRPF4
complexes contained USP39 and USP15 (Figure 6B, Table
S4). Differences in associated proteins suggest that these
Dubs play distinct roles in ubiquitin-dependent control of
mRNA splicing and/or decay.
The ubiquitin system plays a major role in the response of cells
to DNA damage. BRCC36 and its regulatory subunit BRE
(BRCC45) have been shown to associate with BRCA1 as well
as the Abraxis complex containing CCDC98/Abraxis and
UIMC1/RAP80 (Sobhian et al., 2007; Wang et al., 2007), which
uses its ubiquitin interaction motifs (UIMs) to target it to ubiquiti-
nated proteins at DNA double-strand breaks. We identified two
additional proteins in association with BRCC36 not previously
linked to the BRCC36 complex: KIAA0157 (ABRO), a protein
related to Abraxis (Wang et al., 2007), and HSCP142, a protein
of unknown function lacking previously described protein inter-
action domains (Figure 6C). IP-MS/MS analysis of BRE,
HSPC142, and UIMC1 revealed extensive crosstalk between
components of the Abraxis complex (Figure 6C). Recently,
HSPC142 was independently identified and demonstrated to
localize to sites of DNA damage and to be required for loading
of the Abraxis complex on double-strand DNA breaks (Wang
et al., 2009), providing further functional validation of ourmetrics.
Finally, a number of proteins were found associated with two or
more components of the BRCC36 complex, suggesting a poten-
tial role for these proteins in the DNA damage response
(Figure 6C).
Budding yeast Ubp3p and its putative substrate targeting
subunit Bre5p control autophagic degradation of ribosomes
(ribophagy) (Kraft et al., 2008). We found that USP10, the human
ortholog of Ubp3p, associates with the Bre5 ortholog G3BP1, as
previously reported (Table S7), and also associates with the
G3BP1 paralog G3BP2 (Figure 6D). Proteomic analysis of
G3BP1 and 2 revealed USP10 in addition to 19 interacting
proteins in common with G3BP1 and 2 (Figure 6D). On the basis
of these four examples, we hypothesize that Dub activity may be
important for a larger fraction of core cellular functions than
previously appreciated.
Functional Validation of VCP Interacting Dubs Reveals
a Role for USP13 in ERAD
A reoccurring theme throughout our Dub interaction landscape is
the association of Dubs with components of the ubiquitin conju-
gation machinery, signifying a high degree of cross-regulation
within the ubiquitin system (Figures 7A, 7B, and S13). Indeed,
26 Dubs contain HCIPs with Pfam domains linking them withubiquitin conjugation, including HECT, RING, and Cullin-based
E3 ubiquitin ligases (Figures 7A and 7B). It is conceivable that
Dubs act broadly upon particular E3s and/or their targets to
promote their stabilization or activity, as has been suggested
for MDM2-USP7, APCCDC20-USP44, and KPC1-USP19 (Lu
et al., 2009; Stegmeier et al., 2007a; Ventii and Wilkinson,
2008). Subsets of Dubs also interact with other components of
the ubiquitin system (Figures 7A–7C). A case in point is the
AAA ATPase VCP/p97, which plays roles in ubiquitin binding,
conjugation, and deconjugation and is essential for ER-associ-
ated degradation (ERAD) of misfolded proteins (Vembar and
Brodsky, 2008). VCP peptides were identified in 32 Dub immune
complexes, but were particularly abundant (>15 TSCs) in YOD1,
USP13, USP50, and VCPIP1 data sets (Figure 7C). Among the
Dubs we found in complex with VCP, VCPIP1 and Ataxin-3
have been previously demonstrated to interact with VCP
(Uchiyama et al., 2002; Wang et al., 2006), and YOD1 is the
human ortholog of S. cerevisiae Otu1 that has also been shown
to bind VCP (Rumpf and Jentsch, 2006).
We therefore focused our attention on USP13, as it had no
known cellular role and was isolated not only with VCP, but
also with three VCP interacting proteins, UFD1, NPL4, and
ETEA/UBDX8 (Figure 7D), which are thought to serve as adap-
tors to link VCP to targets (Vembar and Brodsky, 2008). On the
basis of these proteins being identified as HCIPs for USP13,
we predicted that USP13 would likely play a role within the
ERAD pathway, and we tested this using a stable cell line ex-
pressing TCRaGFP, a well-established model ERAD substrate
(DeLaBarre et al., 2006). As expected, knockdown of VCP,
PSMD7, and PSMD14 all resulted in a more than 8-fold increase
in TCRaGFP levels (Figures 7E and 7F). Depletion of USP13 with
two separate small interfering RNAs (siRNAs) resulted in a 1.5- to
2-fold accumulation of TCRaGFP relative to control siRNA trans-
fections, while depletion of Hrd1, the known E3 for TCRaGFP
(Kikkert et al., 2004), only caused a 1.2- to 1.5-fold increase
(Figures 7E and 7F). Depletion of the other VCP interacting
Dubs, USP50, YOD1, and VCPIP1, as well as USP10 (which
did not interact with VCP), had no effect on TCRaGFP levels,
while depletion of Ataxin-3 caused a small but consistent 1.25-
fold decrease in TCRaGFP, as expected (Wang et al., 2006)
(Figure 7E; depletion was validated by western blotting shown
in Figure S14E).
Interestingly, knockdown of USP13, VCP, PSMD7, or PSMD14
all resulted in elevated fluorescence levels of a ubiquitin-depen-
dent cytoplasmic GFP reporter based on the CL1 degron (Ben-
nett et al., 2005) (Figure S14B), consistent with an additional
role for a VCP complex in the degradation of non-ER-associated
substrates (Wang et al., 2008). In contrast, depletion of USP13
or VCP had no effect on a cytoplasmic ubiquitin-independent
GFP reporter based on the ornithine decarboxylase degron
(Figure S14A). Consistent with destruction of this reporter via
the proteasome, siRNAs targeting PSMD7 andPSMD14 resulted
in increased fluorescence of this reporter similar to that seenwith
MG132 treatment (Figure S14A).
To further investigate the role of USP13 in ERAD, we utilized
a cell viability assay in combination with tunicamycin, a drug
that inhibits glycosylation within the ER and initiates the unfolded
protein response leading to cell death (Malhotra and Kaufman,Cell 138, 389–403, July 24, 2009 ª2009 Elsevier Inc. 399
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2007). Depletion of PSMD7, PSMD14, VCP, or USP13 resulted in
hypersensitivity to tunicamycin-mediated cell death relative to
the amount detected with control siRNA transfections
(Figure 7G). Depletion of VCPIP1 or USP10 had no significant
effect on cell viability after tunicamycin treatment; however,
depletion of Ataxin-3 resulted in a greater than 2.5-fold resis-
tance to tunicamycin (Figure 7G). The phenotypes of USP13
and Ataxin-3 depletion in the tunicamycin sensitivity and
TCRaGFP stability assays indicated that Ataxin-3 and USP13
have opposing functions within ERAD. Our results, as well as
previously published reports regarding Ataxin-3 (Wang et al.,
2006), indicate that Ataxin-3 directly deubiquitinates ERAD
substrates such as TCRaGFP, and thus removal of this Dub
would allow increased E3 ligase activity, accelerated protein
turnover, and increased flux through the ERAD pathway.
Because depletion of USP13 or VCP results in stabilization of
TCRaGFP, we hypothesize that USP13 functions in regulating
the activity of the VCP complex itself and/or other ubiquitin
ligases that promote TCRaGFP turnover.
Concluding Remarks
This study provides the first glimpse of the Dub interactome by
identifying stably associated proteins for 75% of the Dubs en-
coded by the human genome, significantly increasing the
number of validated and candidate Dub-associated proteins.
The majority of Dubs examined in this study can either be placed
within a large multisubunit complex or in the context of a cellular
process, based on established annotation for their interactors.
Indeed, only one-third of the Dubs in our study cannot be as-
signed a candidate functional role because of either a small
number of HCIPs or the absence of GO annotation. The finding
that Dubs are frequently associated with multiprotein complexes
was somewhat unexpected. On one hand, Dubs associated with
such complexes may function to regulate the activity of the
complex by removing regulatory ubiquitination events. Alterna-
tively, Dub-associated proteins may regulate the activity or
substrate specificity of the Dub, as appears to be the case
with WDR48. Importantly, our analysis failed to identify
substrates for the small number of Dubs where such targets
are known (Ventii and Wilkinson, 2008), likely because of the
transient nature of the Dub-substrate interaction and/or the low
steady-state abundance of these proteins. Additional methods,
such as utilizing catalytically inactive Dubs as a basis for
complex identification, a method previously used to identifyhistone H2A as a substrate of USP3 (Nicassio et al., 2007), will
likely be required to identify Dub substrates. In this regard, initial
experiments using this methodology identified histone H2A as an
HCIP for catalytically inactive USP3C168S (E.J.B. and M.E.S.,
unpublished data), whereas H2A was not found in the wild-
type USP3 IP-MS/MS analysis. It is also possible that distinct
Dub-associated proteins may have been missed in our analysis
if specific stimuli are required for this interaction to occur.
Finally, the analysis of the Dub interactome has been accom-
plished through the development and use of CompPASS, an
integrated platform for analyzing proteomic data. Utilizing
protein network analysis tools contained within CompPASS,
we predicted a role for USP13, a Dub with no previously known
cellular role, within the ERAD pathway. We tested and validated
this prediction through functional studies. The tools within
CompPASS are applicable to proteomic investigations ranging
from focused studies on a small number of selected proteins
to the analysis of entire protein families or biological regulatory
networks.
EXPERIMENTAL PROCEDURES
Protein Expression, Purification, and Functional Validation
Open reading frames for Dubs and associated proteins (Table S2) were cloned
into constitutive or inducible retroviral vectors and expressed in HEK cells (see
the Supplemental Experimental Procedures). For purification, 107 cells were
lysed in 4ml lysis buffer (50mMTris-HCl [pH 7.5], 150mMNaCl, 0.5%Nonidet
P40, and protease inhibitors). Cleared lysates were filtered through 0.45 mM
spin filters (Millipore Ultrafree-CL) and immunoprecipitated with 30 ml anti-
HA resin (Sigma). Complexes were washed with lysis buffer, exchanged into
PBS, eluted with HA peptide and precipitated with 10% TCA. Detailed
methods, including validation of interactions, microscopic localization of
GFP-tagged proteins, and functional analysis of ERAD pathway are provided
in the Supplemental Experimental Procedures.
Mass Spectrometry
TCA-precipitated proteins were trypsinized, purified with Empore C18 extrac-
tion media (3 M), and analyzed via LC-MS/MS with a LTQ linear ion trap mass
spectrometer (ThermoFinnigan) with an 18 cm3 125 mm (ID) C18 column and
a 50 min 8%–26% acetonitrile gradient. Spectra were searched with Sequest
against a target-decoy human tryptic peptide database, and these results
were loaded into CompPASS for further processing and analysis (see the
Supplemental Experimental Procedures).
CompPASS and Bioinformatics
Details of how CompPASS processes and analyzes MS/MS data are provided
in the Supplemental Experimental Procedures. CompPASS is accessible at
http://pathology.hms.harvard.edu/labs/harper/Welcome.html.Figure 7. Functional Validation of USP13 within the ERAD Pathway
(A and B) HCIPs with Pfam domains associated with the ubiquitin-proteasome pathway found in association with Dubs (A). The number of HCIPs with the
indicated Pfam domains found associated with particular Dubs is shown by the rainbow scale. The number of Dubs with HCIPs containing the indicated
Pfam domains (orange bars) as well as the number of HCIPs containing the indicated domains (blue bars) are shown in (B).
(C) TSCs corresponding to VCP/p97 identified within immune complexes of indicated Dubs.
(D) Schematic representation of USP13 and select HCIPs known to associate with VCP and their annotated Pfam domains.
(E) TCRaGFP cellular fluorescence levels after knockdown of indicated genes. Two siRNA oligos were used against each gene. Fluorescence levels are relative to
control siRNA transfection (siCK). For western blots confirming knockdown, see Figure S14.
(F) Histograms of TCRaGFP fluorescence after knockdown of indicated genes.
(G) Cell viability, as measured by cellular ATP levels, was measured 72 hr after siRNA transfection and 48 hr after addition of 0.3 mg/mL tunicamycin to the growth
media. All values are relative to the amount viability measured after control siRNA transfection (siCK).
Error bars represent the SEM of triplicate measurements. *p < 0.05, **p < 0.01, as determined by Student’s t test. All samples the rightmost graph in (E) have
a p value < 0.01 compared to the control knockdown.Cell 138, 389–403, July 24, 2009 ª2009 Elsevier Inc. 401
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